GRASS (Grass MATA MPL Real-world Assessment Study)

by palligoelme@gmail.com | Feb 17, 2026 | Clinical Trials

​ Conditions: Grass Pollen Allergy Interventions: Drug: Grassmuno® Sponsors: Allergy Therapeutics; Bencard Allergie GmbH; ClinCompetence Cologne GmbH Not yet recruiting Conditions: Grass Pollen Allergy Interventions: Drug: Grassmuno® Sponsors: Allergy Therapeutics;...

VLA1553-403 Pregnancy Surveillance Study

by palligoelme@gmail.com | Feb 17, 2026 | Clinical Trials

​ Conditions: Chikungunya Virus Infection Interventions: Biological: Live-attenuated CHIKV vaccine VLA1553; Biological: Vaccine(s) approved for use during pregnancy by the MoH Sponsors: Valneva Austria GmbH; Fundação Butantan; Coalition for Epidemic Preparedness...

Advanced MRI in IVH

by palligoelme@gmail.com | Feb 17, 2026 | Clinical Trials

​ Conditions: Intraventricular Hemorrhage Neonatal; Post-hemorrhagic Hydrocephalus Interventions: Diagnostic Test: Advanced MRI Sponsors: Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children’s NHS Foundation Trust Not yet...

A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants

by palligoelme@gmail.com | Feb 17, 2026 | Clinical Trials

​ Conditions: Pharmakokinetic; Open Label; Phase 1 Interventions: Drug: TNX-102 SL Tablet Sponsors: Tonix Pharmaceuticals, Inc.; Syneos Health Active, not recruiting Conditions: Pharmakokinetic; Open Label; Phase 1 Interventions: Drug: TNX-102 SL Tablet Sponsors:...

A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers

by palligoelme@gmail.com | Feb 17, 2026 | Clinical Trials

​ Conditions: Healthy Volunteer Interventions: Drug: ABBV-8736; Drug: ABBV-8736 Sponsors: AbbVie Not yet recruiting Conditions: Healthy Volunteer Interventions: Drug: ABBV-8736; Drug: ABBV-8736 Sponsors: AbbVie Not yet...